ATLANTA, March 01, 2017 -- DLH Holdings Corp. (NASDAQ:DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to Federal agencies, today announced that it will participate in the 29th Annual Roth Capital Conference in Dana Point, California. A presentation, to be webcast, is currently scheduled for Wednesday, March 15 at 11:30 a.m. Pacific time; please check the website for any changes to this timing, as may occur prior to the anticipated date. Institutional investors are welcome to meet with management on Tuesday and Wednesday, March 14 and 15.
Additional information will be posted on the Company’s website when available, including a live audio webcast. To hear the presentation and view related materials, please visit the website at www.dlhcorp.com. A replay is typically available for ninety days.
About DLH
DLH (NASDAQ:DLHC) serves clients throughout the United States as a healthcare and human services provider to the Federal Government. The Company’s core competencies include assessment & compliance monitoring, business process outsourcing, health IT systems integration and management, readiness and medical logistics, and pharmacy solutions. DLH has over 1,400 employees working throughout the country. For more information, visit the corporate website at www.dlhcorp.com.
CONTACTS: COMMUNICATIONS Contact: Tiffany McCall Phone: 404-334-6000 Email: [email protected] INVESTOR RELATIONS Contact: Chris Witty Phone: 646-438-9385 Email: [email protected]


BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



